Posted by Michael Wonder on 23 Nov 2020
Funding changes to dornase alfa for cystic fibrosis
23 November 2020 - From 1 December 2020 dornase alfa will be listed in the Community and the Hospital Medicines List of the Pharmaceutical Schedule.
Current Special Authority approvals will be transferred to the standard Special Authority system.
